Discontinued medicines · Evaluating
Bringing back medicines patients still need.
Medicines are often discontinued not because they stopped working, but because demand became too small to justify a production line. 3D printing makes these small volumes economical again.
The gap
When a production line stops, patients lose supply.
Mass manufacturing only pays at hundreds of thousands of identical units. When demand falls below that, a medicine can disappear, leaving the patients who rely on it without supply.
Our approach
Two routes back to patients.
PharmaTher plans to identify discontinued medicines with ongoing patient need and bring them back.
FDA abbreviated pathways
Applications that reference the original approval, once the FDA confirms the product was not withdrawn for safety or effectiveness reasons.
503A compounding
Patient-specific prescriptions prepared by licensed pharmacies, where permitted.
Candidate selection, 2027–2028
Know of a discontinued medicine patients still need? We'd like to hear about it.
Tell us about a medicineSee the full pipeline
Five areas where a precise dose, a combination or a small batch makes a medicine possible.
Pipeline overviewReintroducing a discontinued medicine depends on FDA confirmation that it was not withdrawn for safety or effectiveness reasons, or on 503A eligibility. Compounded drugs are not approved by the FDA. Plans and timelines are internal estimates and forward-looking.